Gil Rabinovici's perspective on "Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab" is now published in the New England Journal of Medicine!
Gil Rabinovici's perspective on "Controversy and Progress in Alzheimer’s Disease — FDA Approval of Aducanumab" is now published in the New England Journal of Medicine!
